(19)
(11) EP 0 517 826 A1

(12)

(43) Date of publication:
16.12.1992 Bulletin 1992/51

(21) Application number: 91906027.0

(22) Date of filing: 01.03.1991
(51) International Patent Classification (IPC): 
A61K 38/ 43( . )
A61P 9/ 08( . )
C07K 14/ 00( . )
C07K 14/ 755( . )
C12N 15/ 09( . )
C12N 15/ 14( . )
C12P 21/ 02( . )
C12R 1/ 19( . )
A61P 7/ 02( . )
A61P 9/ 10( . )
C07K 14/ 47( . )
C12N 1/ 21( . )
C12N 15/ 12( . )
C12P 21/ 00( . )
A61K 38/ 00( . )
(86) International application number:
PCT/US1991/001416
(87) International publication number:
WO 1991/013093 (05.09.1991 Gazette 1991/21)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IT LI LU NL SE

(30) Priority: 02.03.1990 US 19900487767

(71) Applicant: BIO-TECHNOLOGY GENERAL CORPORATION
New York NY 10001 (US)

(72) Inventors:
  • GARFINKEL, Leonard
    00 230 Rehovot (IL)
  • RICHTER, Tamar
    70 400 Nes Ziona (IL)

(74) Representative: VOSSIUS & PARTNER 
Postfach 86 07 67
D-81634 München
D-81634 München (DE)

   


(54) CLONING AND PRODUCTION OF HUMAN VON WILLEBRAND FACTOR GPIb BINDING DOMAIN POLYPEPTIDES AND METHODS OF USING SAME